Longevity
Early research suggests GLP-1s may influence biological markers of aging.
GLP-1 Microdose Protocols for Longevity
* Compounded GLP-1 products are not FDA-approved. Prescription required. Individual results may vary. Not a substitute for professional medical advice. Prescription products require an online consultation and are only available if prescribed by a licensed provider.
What the research is saying
GLP-1 can activate key pathways linked to healthy aging. Microdosing may keep these pathways engaged at lower doses, with fewer side effects*
Early research suggests GLP-1s may influence biological markers of aging.
Clinical studies show reduced markers of chronic inflammation.
Large trials show fewer heart attacks, strokes, and cardiovascular deaths.
Emerging evidence points to brain health benefits.
May support healthy blood sugar and body composition.
A gentler on-ramp may mean fewer side effects.
* Citations reference studies that may include standard-dose GLP-1 data. Benefits highlighted for cognition, aging, and inflammation are based on early-stage or observational research and have not been validated in large-scale clinical trials.